跳至主要内容
临床试验/EUCTR2006-006867-22-CZ
EUCTR2006-006867-22-CZ进行中(未招募)1 期

Treatment of proteinuria with angiotensin-converting enzyme inhibitor in children after renal transplantation

niversity Hospital Motol0 个研究点开始时间: 2006年12月19日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients up to 18 years at least 6 months after renal transplantation with functional graft and persistent proteinuria >200mg/m2/day (on 2 consecutive occasions at least 1 month apart) not being treated with ACE-inhibitors.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • stenosis of graft artery, acute rejection < 3 months before study entry, severe chronic allograft nephropathy with severely reduced glomerular filtration rate (estimated creatinine clearance <30 ml/min/1.73m2), patients with hypotension, patients with a history of allergic or other adverse effects of ACE-inhibitors, pregnancy.

研究者

发起方
niversity Hospital Motol

相似试验